These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11084672)

  • 1. Human Fascioliasis in The Metropolitan Area of Curitiba, Brazil Evaluation of The Foci of Infection and Report of Nine Cases Treated With Triclabendazole.
    Luz JE; Focaccia Siciliano R ; de Oliveira AG; Pisani JC
    Braz J Infect Dis; 1999 Dec; 3(6):220-225. PubMed ID: 11084672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.
    Talaie H; Emami H; Yadegarinia D; Nava-Ocampo AA; Massoud J; Azmoudeh M; Mas-Coma S
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):777-82. PubMed ID: 15566392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica.
    Valero MA; Perez-Crespo I; Periago MV; Khoubbane M; Mas-Coma S
    Acta Trop; 2009 Aug; 111(2):150-9. PubMed ID: 19375410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of metronidazole in treating human fascioliasis.
    Mansour-Ghanaei F; Shafaghi A; Fallah M
    Med Sci Monit; 2003 Oct; 9(10):PI127-30. PubMed ID: 14523339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascioliasis imported to Norway.
    Jensenius M; Flaegstad T; Stenstad T; Gjølberg T; Vlatkovic L; Schjøth-Iversen L; Berild D; Bordmann G; Myrvang B
    Scand J Infect Dis; 2005; 37(6-7):534-7. PubMed ID: 16012024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
    Keiser J; Utzinger J; Vennerstrom JL; Dong Y; Brennan G; Fairweather I
    Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1219-22. PubMed ID: 17905370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triclabendazole in the treatment of human fascioliasis: a community-based study.
    el-Morshedy H; Farghaly A; Sharaf S; Abou-Basha L; Barakat R
    East Mediterr Health J; 1999 Sep; 5(5):888-94. PubMed ID: 10983527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstruction of common bile duct caused by liver fluke--Fasciola hepatica.
    Kiladze M; Chipashvili L; Abuladze D; Jatchvliani D
    Sb Lek; 2000; 101(3):255-9. PubMed ID: 11220154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of triclabendazole (Fasinex) in children with fasciolosis.
    Yilmaz H; Oner AF; Akdeniz H; Arslan S
    J Egypt Soc Parasitol; 1998 Aug; 28(2):497-502. PubMed ID: 9707678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Four cases of hepatic fascioliasis mimicking cholangiocarcinoma].
    Kim YH; Kang KJ; Kwon JH
    Korean J Hepatol; 2005 Jun; 11(2):169-75. PubMed ID: 15980676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam.
    Hien TT; Truong NT; Minh NH; Dat HD; Dung NT; Hue NT; Dung TK; Tuan PQ; Campbell JI; Farrar JJ; Day JN
    Am J Trop Med Hyg; 2008 Mar; 78(3):388-92. PubMed ID: 18337331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human fascioliasis symptoms. A case report with review of the literature].
    Helfenstein E; Kayser S; Locher G
    Praxis (Bern 1994); 2000 Sep; 89(36):1427-35. PubMed ID: 11031859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight cases of fascioliasis: clinical and microbiological features.
    Dauchy FA; Vincendeau P; Lifermann F
    Med Mal Infect; 2006 Jan; 36(1):42-6. PubMed ID: 16309872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fascioliasis: diagnosis, epidemiology and treatment].
    Carrada-Bravo T
    Rev Gastroenterol Mex; 2003; 68(2):135-42. PubMed ID: 15127652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical tumor caused by the sexually mature stage of Fasciola hepatica.
    Marcos LA; Légua P; Sánchez J; Espinoza JR; Yi P; Tantaleán M
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):318-20. PubMed ID: 19046753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the flukicide treatment policy for dairy cattle in Galicia (NW Spain).
    Mezo M; González-Warleta M; Castro-Hermida JA; Ubeira FM
    Vet Parasitol; 2008 Nov; 157(3-4):235-43. PubMed ID: 18774648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland.
    Mooney L; Good B; Hanrahan JP; Mulcahy G; de Waal T
    Vet Parasitol; 2009 Oct; 164(2-4):201-5. PubMed ID: 19556063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.